FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.24 | FHIR Version n/a User: [n/a]

10264711000001106: Clarelux 500micrograms/g foam (Pierre Fabre Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Clarelux 500micrograms/g foam (Pierre Fabre Ltd)
\UK product\Virtual medicinal product\Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous foam\Clarelux 500micrograms/g foam (Pierre Fabre Ltd)
\UK product\Virtual therapeutic moiety\Clobetasol\Product containing only clobetasol in cutaneous dose form (medicinal product form)\Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous foam\Clarelux 500micrograms/g foam (Pierre Fabre Ltd)
\UK product\Virtual therapeutic moiety\Clobetasol\Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous foam\Clarelux 500micrograms/g foam (Pierre Fabre Ltd)
\UK product\Trade family\Clarelux\Clarelux 500micrograms/g foam (Pierre Fabre Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2082961000001118 Clarelux 500micrograms/g foam (Pierre Fabre Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2082971000001111 Clarelux 500micrograms/g foam (Pierre Fabre Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	VMP non-availability indicator	Re-introduced	true	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Is a	Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous foam	true	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Has active ingredient	Clobetasol propionate	false	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Has active ingredient	Glucocorticoid hormone	false	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Has excipient	Cetyl alcohol	false	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Has excipient	Stearyl alcohol	false	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Has manufactured dose form	Foam	false	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Is a	Clarelux	true	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Has specific active ingredient	Clobetasol propionate	true	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Has dispensed dose form	Foam	true	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Has manufactured dose form	Cutaneous AND/OR transdermal dosage form	false	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	VMP non-availability indicator	Not available	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) 100 gram	Is pack of	False	Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Inferred relationship	Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) 100 gram	Has AMP	True	Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2082961000001118	Clarelux 500micrograms/g foam (Pierre Fabre Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2082971000001111	Clarelux 500micrograms/g foam (Pierre Fabre Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module